Staidson
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.23
Market Cap
CNY5.68 B
Shares Outstanding
466.65 M
Public Float
155.74 M

Profile

Address
36 Jinghai 2nd Road
Beijing Beijing 100176
China
Employees -
Website http://www.staidson.com
Updated 07/08/2019
Staidson (Beijing) Biopharmaceuticals Co., Ltd. engages in the research, development, production, and sale of independent intellectual property innovation drugs. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin. The company was founded on August 16, 2002 and is headquartered in Beijing, China.

Financials

View All
Created with Highcharts 5.0.14StaidsonNet Income. Fiscal year is January-December. All values CNY Millions.110110195195211211257257263263134134201320142015201620172018050100150200250300
Created with Highcharts 5.0.14StaidsonSales/Revenue. Fiscal year is January-December. All values CNY Millions.8858851 0861 0861 2421 2421 3961 3961 3781 3787997992013201420152016201720180250500750100012501500

Zhi Wen Zhou
Chairman
Hong Shan Zhang
Chairman-Supervisory Board